GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Collegium Pharmaceutical Inc (FRA:354) » Definitions » Cyclically Adjusted PB Ratio

Collegium Pharmaceutical (FRA:354) Cyclically Adjusted PB Ratio : 4.99 (As of Jun. 01, 2025)


View and export this data going back to 2016. Start your Free Trial

What is Collegium Pharmaceutical Cyclically Adjusted PB Ratio?

As of today (2025-06-01), Collegium Pharmaceutical's current share price is €25.20. Collegium Pharmaceutical's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was €5.05. Collegium Pharmaceutical's Cyclically Adjusted PB Ratio for today is 4.99.

The historical rank and industry rank for Collegium Pharmaceutical's Cyclically Adjusted PB Ratio or its related term are showing as below:

FRA:354' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 4.75   Med: 6.81   Max: 8.81
Current: 5.25

During the past years, Collegium Pharmaceutical's highest Cyclically Adjusted PB Ratio was 8.81. The lowest was 4.75. And the median was 6.81.

FRA:354's Cyclically Adjusted PB Ratio is ranked worse than
83.29% of 694 companies
in the Drug Manufacturers industry
Industry Median: 1.94 vs FRA:354: 5.25

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Collegium Pharmaceutical's adjusted book value per share data for the three months ended in Mar. 2025 was €6.749. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €5.05 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Collegium Pharmaceutical Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Collegium Pharmaceutical's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Collegium Pharmaceutical Cyclically Adjusted PB Ratio Chart

Collegium Pharmaceutical Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 6.83 5.57

Collegium Pharmaceutical Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.35 6.81 8.04 5.57 5.38

Competitive Comparison of Collegium Pharmaceutical's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Collegium Pharmaceutical's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Collegium Pharmaceutical's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Collegium Pharmaceutical's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Collegium Pharmaceutical's Cyclically Adjusted PB Ratio falls into.


;
;

Collegium Pharmaceutical Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Collegium Pharmaceutical's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=25.20/5.05
=4.99

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Collegium Pharmaceutical's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Collegium Pharmaceutical's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=6.749/134.9266*134.9266
=6.749

Current CPI (Mar. 2025) = 134.9266.

Collegium Pharmaceutical Quarterly Data

Book Value per Share CPI Adj_Book
201506 4.411 100.684 5.911
201509 4.030 100.392 5.416
201512 3.766 99.792 5.092
201603 4.649 100.470 6.243
201606 3.732 101.688 4.952
201609 2.807 101.861 3.718
201612 4.355 101.863 5.769
201703 3.630 102.862 4.762
201706 2.875 103.349 3.753
201709 2.625 104.136 3.401
201712 2.684 104.011 3.482
201803 2.230 105.290 2.858
201806 2.133 106.317 2.707
201809 1.825 106.507 2.312
201812 2.420 105.998 3.080
201903 2.289 107.251 2.880
201906 2.273 108.070 2.838
201909 2.282 108.329 2.842
201912 2.336 108.420 2.907
202003 3.721 108.902 4.610
202006 4.010 108.767 4.974
202009 4.240 109.815 5.210
202012 4.418 109.897 5.424
202103 4.057 111.754 4.898
202106 5.913 114.631 6.960
202109 6.134 115.734 7.151
202112 5.336 117.630 6.121
202203 5.248 121.301 5.838
202206 5.481 125.017 5.915
202209 5.897 125.227 6.354
202212 5.434 125.222 5.855
202303 4.854 127.348 5.143
202306 5.339 128.729 5.596
202309 5.069 129.860 5.267
202312 5.623 129.419 5.862
202403 6.249 131.776 6.398
202406 6.225 132.554 6.336
202409 6.549 133.029 6.642
202412 6.951 133.157 7.043
202503 6.749 134.927 6.749

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Collegium Pharmaceutical  (FRA:354) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Collegium Pharmaceutical Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Collegium Pharmaceutical's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Collegium Pharmaceutical Business Description

Traded in Other Exchanges
Address
100 Technology Center Drive, Stoughton, MA, USA, 02072
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

Collegium Pharmaceutical Headlines

No Headlines